| 1 | Pediatric Cancer Screening in Hereditary Gastrointestinal Cancer Risk Syndromes: An Update from the AACR Childhood Cancer Predisposition Working Group. (MacFarland SP, Becktell K, Schneider KW, Kuiper RP, Lesmana H, Meade J, Nichols KE, Porter CC, Savage SA, Schultz KA, Scott H, States L, Tabori U, Tamura C, Tomlinson G, Zelley K, Durno C, Bauer A, Plon SE) Clin Cancer Res 2024 Oct 15;30(20):4566-4571 2 Citations |
| 1 | ASO Practice Guidelines Series: Surgical Management of Gastrointestinal (Midgut) Neuroendocrine Neoplasms. (Hallet J, Clarke CN) Ann Surg Oncol 2024 Mar;31(3):1704-1713 5 Citations |
| 1 | Elucidating the Benefit of Radiation Therapy in GI Cancers: Rethinking Trial End Points and Patient Selection. (Sanford NN, Hong TS, Hall WA) J Clin Oncol 2024 Mar 10;42(8):868-871 7 Citations |
| 1 | Establishment of Patient-Derived Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumor Models for Predicting Therapeutic Response. (Yebra M, Bhargava S, Kumar A, Burgoyne AM, Tang CM, Yoon H, Banerjee S, Aguilera J, Cordes T, Sheth V, Noh S, Ustoy R, Li S, Advani SJ, Corless CL, Heinrich MC, Kurzrock R, Lippman SM, Fanta PT, Harismendy O, Metallo C, Sicklick JK) Clin Cancer Res 2022 Jan 01;28(1):187-200 23 Citations |
| 1 | Tumor mutational burden is not predictive of cytotoxic chemotherapy response. (Nikanjam M, Riviere P, Goodman A, Barkauskas DA, Frampton G, Kurzrock R) Oncoimmunology 2020 Jun 24;9(1):1781997 12 Citations |
| 1 | The Chicago Consensus on Peritoneal Surface Malignancies: Management of Desmoplastic Small Round Cell Tumor, Breast, and Gastrointestinal Stromal Tumors. (Chicago Consensus Working Group) Ann Surg Oncol 2020 Jun;27(6):1793-1797 14 Citations |
| 1 | The Chicago Consensus on peritoneal surface malignancies: Management of desmoplastic small round cell tumor, breast, and gastrointestinal stromal tumors. (Chicago Consensus Working Group) Cancer 2020 Jun 01;126(11):2566-2570 9 Citations |
| 1 | The CXCL12-CXCR4/CXCR7 axis as a mechanism of immune resistance in gastrointestinal malignancies. (Daniel SK, Seo YD, Pillarisetty VG) Semin Cancer Biol 2020 Oct;65:176-188 149 Citations |
| 1 | Effect of Lanreotide Depot/Autogel on Urinary 5-Hydroxyindoleacetic Acid and Plasma Chromogranin A Biomarkers in Nonfunctional Metastatic Enteropancreatic Neuroendocrine Tumors. (Pavel ME, Phan AT, Wolin EM, Mirakhur B, Liyanage N, Pitman Lowenthal S, Fisher GA Jr, Vinik AI, CLARINET Study Investigators) Oncologist 2019 Apr;24(4):463-474 15 Citations |
| 1 | Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. (Liu Y, Sethi NS, Hinoue T, Schneider BG, Cherniack AD, Sanchez-Vega F, Seoane JA, Farshidfar F, Bowlby R, Islam M, Kim J, Chatila W, Akbani R, Kanchi RS, Rabkin CS, Willis JE, Wang KK, McCall SJ, Mishra L, Ojesina AI, Bullman S, Pedamallu CS, Lazar AJ, Sakai R, Cancer Genome Atlas Research Network, Thorsson V, Bass AJ, Laird PW) Cancer Cell 2018 Apr 09;33(4):721-735.e8 398 Citations |
| 1 | Hybrid Capture-Based Genomic Profiling of Circulating Tumor DNA from Patients with Advanced Cancers of the Gastrointestinal Tract or Anus. (Schrock AB, Pavlick D, Klempner SJ, Chung JH, Forcier B, Welsh A, Young L, Leyland-Jones B, Bordoni R, Carvajal RD, Chao J, Kurzrock R, Sicklick JK, Ross JS, Stephens PJ, Devoe C, Braiteh F, Ali SM, Miller VA) Clin Cancer Res 2018 Apr 15;24(8):1881-1890 57 Citations |
| 1 | The Mutational Landscape of Gastrointestinal Malignancies as Reflected by Circulating Tumor DNA. (Riviere P, Fanta PT, Ikeda S, Baumgartner J, Heestand GM, Kurzrock R) Mol Cancer Ther 2018 Jan;17(1):297-305 33 Citations |
| 1 | Divergent viral presentation among human tumors and adjacent normal tissues. (Cao S, Wendl MC, Wyczalkowski MA, Wylie K, Ye K, Jayasinghe R, Xie M, Wu S, Niu B, Grubb R 3rd, Johnson KJ, Gay H, Chen K, Rader JS, Dipersio JF, Chen F, Ding L) Sci Rep 2016 Jun 24;6:28294 56 Citations |
| 1 | Treatment of Liver Tumors with Lipiodol TACE: Technical Recommendations from Experts Opinion. (de Baere T, Arai Y, Lencioni R, Geschwind JF, Rilling W, Salem R, Matsui O, Soulen MC) Cardiovasc Intervent Radiol 2016 Mar;39(3):334-43 223 Citations |
| 1 | Squamousness: Next-generation sequencing reveals shared molecular features across squamous tumor types. (Schwaederle M, Elkin SK, Tomson BN, Carter JL, Kurzrock R) Cell Cycle 2015;14(14):2355-61 59 Citations |
| 1 | Advances in the treatment of gastroenteropancreatic neuroendocrine tumors. (Phan AT) Clin Adv Hematol Oncol 2014 Dec;12(12 Suppl 19):3-5 2 Citations |
| 1 | A nomogram to predict disease-free survival after surgical resection of GIST. (Bischof DA, Kim Y, Behman R, Karanicolas PJ, Quereshy FA, Blazer DG 3rd, Maithel SK, Gamblin TC, Bauer TW, Pawlik TM) J Gastrointest Surg 2014 Dec;18(12):2123-9 28 Citations |
| 1 | Lanreotide in metastatic enteropancreatic neuroendocrine tumors. (Caplin ME, Pavel M, Ćwikła JB, Phan AT, Raderer M, Sedláčková E, Cadiot G, Wolin EM, Capdevila J, Wall L, Rindi G, Langley A, Martinez S, Blumberg J, Ruszniewski P, CLARINET Investigators) N Engl J Med 2014 Jul 17;371(3):224-33 1088 Citations |
| 1 | Percutaneous transfacial direct embolization of an intraosseous dural arteriovenous fistula. (Nerva JD, Hallam DK, Ghodke BV) Neurosurgery 2014 Mar;10 Suppl 1:E178-82 9 Citations |
| 1 | BRAF mutant gastrointestinal stromal tumor: first report of regression with BRAF inhibitor dabrafenib (GSK2118436) and whole exomic sequencing for analysis of acquired resistance. (Falchook GS, Trent JC, Heinrich MC, Beadling C, Patterson J, Bastida CC, Blackman SC, Kurzrock R) Oncotarget 2013 Feb;4(2):310-5 143 Citations |
| 1 | Survival of 1,181 patients in a phase I clinic: the MD Anderson Clinical Center for targeted therapy experience. (Wheler J, Tsimberidou AM, Hong D, Naing A, Falchook G, Piha-Paul S, Fu S, Moulder S, Stephen B, Wen S, Kurzrock R) Clin Cancer Res 2012 May 15;18(10):2922-9 82 Citations |
| 1 | American Society for Radiation Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of high-dose-rate brachytherapy. (Erickson BA, Demanes DJ, Ibbott GS, Hayes JK, Hsu IC, Morris DE, Rabinovitch RA, Tward JD, Rosenthal SA) Int J Radiat Oncol Biol Phys 2011 Mar 01;79(3):641-9 40 Citations |
| 3 | Adamantinoma with plasmacytoid features: expanding the spectrum of a diagnostically challenging entity. (Walters MP, Baynes K, Carrera GF, King DM, Wang D, Charlson J, Zambrano E) Ann Diagn Pathol 2011 Oct;15(5):347-54 2 Citations |
| 1 | A phase I dose escalation study of a pharmacobiologically based scheduling of capecitabine and mitomycin C in patients with gastrointestinal malignancies. (Bekaii-Saab T, Hill M, Campbell A, Kosuri K, Thomas J, Villalona-Calero M) Cancer Chemother Pharmacol 2010 Apr;65(5):863-9 |
| 1 | Palliative stenting for late malignant gastric outlet obstruction. (Kiely JM, Dua KS, Graewin SJ, Nakeeb A, Erickson BA, Ritch PS, Wilson SD, Pitt HA) J Gastrointest Surg 2007 Jan;11(1):107-13 7 Citations |
| 1 | Concurrent capecitabine and upper abdominal radiation therapy is well tolerated. (Das P, Wolff RA, Abbruzzese JL, Varadhachary GR, Evans DB, Vauthey JN, Baschnagel A, Delclos ME, Krishnan S, Janjan NA, Crane CH) Radiat Oncol 2006 Oct 24;1:41 20 Citations |
| 1 | Significance and management of local recurrences and limited metastatic disease in the abdomen. (Windham TC, Pearson AS, Skibber JM, Mansfield PF, Lee JE, Pisters PW, Evans DB) Surg Clin North Am 2000 Apr;80(2):761-74, xii 8 Citations |
| 1 | Advances in the diagnosis and treatment of gastrointestinal neuroendocrine tumors. (Lee JE, Evans DB) Cancer Treat Res 1997;90:227-38 5 Citations |
| 1 | The cutaneous manifestations of gastrointestinal disease. (Katz SK, Gordon KB, Roenigk HH) Prim Care 1996 Sep;23(3):455-76 12 Citations |
| 1 | Carcinoembryonic antigen elevation: red herring or. . . ? (Sobin WH, Barkin JS, Rogers AI) Compr Ther 1982 Aug;8(8):44-7 |
